Drawing for INFIRST +

USPTO serial 79143149

INFIRST +

Reviewed by CopyMark Law Group

Reg. 4643099Status 404
Filing date
Status date
Registration date
Nov 25, 2014
Examiner
LEHKER, DAWN FELDMAN
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFIRST +?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and veterinary preparations, namely, pharmaceutical preparations and substances for the treatment of pain, pain relief medication, cough treatment preparations, preparations for treating colds, pharmaceutical preparations for wounds, medical adhesives for binding wounds, anti-inflammatory and antipyretic preparations, antipyretic preparations, antipyretic analgesics, analgesics, anti-inflammatories, pharmaceutical preparations and substances for the treatment of inflammation and antihistamines; medical plasters; medications, namely, medicated shampoo, allergy medication, acne medications, burn relief medication, diarrhea medication, pain relief medication, medications for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; nutritional supplements; vitamin and mineral supplements; bacteriological preparations for medical purposes; diagnostic preparations for medical purposes; vaccinesSECTION 70 - CANCELLED—
042Scientific and technological research and development in the fields of human and veterinary pharmaceuticals; medical research; scientific research; pharmaceutical drug development services; pharmaceutical product evaluation, namely, clinical scientific evaluation of pharmaceuticals; research and development for others in the field of pharmaceuticals; technical consulting services in relation to scientific research; drug discovery services; development of pharmaceutical and therapeutic preparations; pharmaceutical research and development; providing scientific information to others about pharmaceuticals, drug delivery systems, vaccines and the formulation of biological and therapeutic preparationsSECTION 70 - CANCELLED—
045[ Licensing of intellectual property; licensing of intellectual property in the fields of medical and scientific technologies; patent and proprietary technology licensing in the field of medicines and pharmaceuticals; legal services, namely, regulatory registration of pharmaceuticals and official licensing of pharmaceutical compounds, namely, tracking and monitoring regulatory requirements in the field of pharmaceuticals for regulatory compliance purposes; regulatory compliance consulting in the fields of chemical, sanitary, food, beverage, nutritional, naturopathic, pharmaceutical, medical, veterinary and healthcare products and services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 30, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 25, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 5, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Oct 26, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 26, 2021INPCINVALIDATION PROCESSED—
Oct 4, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 4, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 4, 202171.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jan 28, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 23, 2020ES71TEAS SECTION 71 RECEIVED—
Oct 31, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 8, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 25, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 21, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 8, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 22, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 22, 2015FIMPFINAL DISPOSITION PROCESSED—
Feb 25, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 15, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 9, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2014NPUBNOTICE OF PUBLICATION—
Aug 2, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 2, 2014ALIEASSIGNED TO LIE—
Jul 24, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 22, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 22, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 7, 2014CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 3, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 20, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 20, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 25, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 25, 2014RFRRREFUSAL PROCESSED BY MPU—
Mar 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2014DOCKASSIGNED TO EXAMINER—
Mar 4, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 28, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance